title: Increased epithelial permeability in pulmonary fibrosis in relation to disease progression.
authors.affiliation: Royal Brompton Hospital and National Heart and Lung Institute, London, UK.
authors.forename: N S L
authors.initials: NS
authors.lastname: Goh
authors.forename: S R
authors.initials: SR
authors.lastname: Desai
authors.forename: C
authors.initials: C
authors.lastname: Anagnostopoulos
authors.forename: D M
authors.initials: DM
authors.lastname: Hansell
authors.forename: R K
authors.initials: RK
authors.lastname: Hoyles
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: C P
authors.initials: CP
authors.lastname: Denton
authors.forename: C M
authors.initials: CM
authors.lastname: Black
authors.forename: R M
authors.initials: RM
authors.lastname: du Bois
authors.forename: A U
authors.initials: AU
authors.lastname: Wells
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D018450:Disease Progression; D004848:Epithelium / Q000473:pathology*; D005260:Female; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010539:Permeability; D011379:Prognosis; D016016:Proportional Hazards Models; D011658:Pulmonary Fibrosis / Q000473:pathology*; D019275:Radiopharmaceuticals / Q000494:pharmacology; D016284:Technetium Tc 99m Pentetate / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D019275:Radiopharmaceuticals; D016284:Technetium Tc 99m Pentetate